UNSPSC 51473001: Benzalkonium chloride

This classification denotes a surface-active agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F5UM2KM3W7. European Medicines Agency schedules Benzalkonium chloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00714MIG. Benzalkonium chloride generally arises in the molecular formula C22H40CLN. The term BENZALKONIUM CHLORIDE is an International Non-Proprietary Name or INN. Most nations schedule benzalkonium chloride under HS 34021200 and SITC 55421.

As of Q4 2014, BENZALKONIUM CHLORIDE remains the US FDA Preferred Term for this commodity. Benzalkonium chloride bears US NLM identifiers UMLS ID C0005026 and NCI Concept Code C82282. SMILES: C[NH+](C)CC1=CC=CC=C1.[Cl-].

UNSPSC 51473001 Benzalkonium chloride is a Commodity code that describes chemical disinfectants and antimicrobial agents used in state and local government operations, particularly by fire rescue services, health departments, and public facilities requiring high-volume consumable supplies for janitorial, operational, and medical applications. State and local issuing bodies purchasing under this code include county governments and multistate cooperative purchasing alliances administering health and safety procurement on behalf of member agencies. Benzalkonium chloride appears in two distinct operational contexts: as a component in janitorial and cleaning supplies for fire stations and public facilities, and as a pharmaceutical and OTC product ingredient distributed through state and local health systems via authorized wholesale channels.

The Hillsborough County Board of County Commissioners issued ITB 26-00319 on July 7, 2026, for janitorial and operational supplies to support 47 fire stations operating 24/7, with a contract value of $765,679.84 and a July 24, 2026 response deadline. The Minnesota Department of Administration's Office of State Procurement, through the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued RFP S1070000015802 on January 20, 2026, to establish multiple contracts for generic pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon, with proposals due March 26, 2026. Both solicitations require authorized distributor status, compliance with supply-chain security and manufacturing standards, and delivery through established wholesale or operational channels. Geographic activity centers on Florida and the Upper Midwest cooperative purchasing region, with contract administration through county facilities and state procurement offices.